AACR next week
3 posters will be presented next week
1) 4601 shuts down ERK
2) 4601 increase efficacy for EGRF inhibitors
3) cytoxicity of 232 dual mecanism
Full posters will be unvail next week.
This should gather some attention.
Tarceva® or Iressa® are not increasing in sales due to relative small population being affected by drug. Combination with 4601 could give em a second life as marketed drugs.
Waiting for peer review and reception!!